摘要
目的:观察鞘内注射核因子-κB(nuclear factor-κB,NF-κB)抑制剂吡咯烷二硫氨基甲酸(pyrrolidine dithiocarbamate,PDTC)对单关节炎(monoarthritis,MA)模型大鼠痛阈值和脊髓中CX3C趋化因子受体-1(CX3C chemokine receptor1,CX3CR1)表达的影响。方法:48只成年雄性Sprague-Dawley大鼠鞘内置管成功后,随机分为4组,即sham组(假手术组)、MA组(单关节炎组)、PDTC预处理组及PDTC后处理组,每组大鼠均为12只。鞘内置管5d后制作MA模型。Sham组:左侧踝关节腔内注射50μL生理盐水,鞘内注射10μL生理盐水;MA组:左侧踝关节腔内注射50μL完全弗氏佐剂(complete Freund'sadjuvant,CFA),鞘内注射10μL生理盐水;PDTC预处理组:鞘内注射10μL PDTC(100μmol/L),30min后左侧踝关节腔内注射50μL CFA;PDTC后处理组:左侧踝关节腔内注射50μL CFA,30min后鞘内注射10μL PDTC(100μmol/L)。于术前及术后不同时间点测定痛阈值,用免疫组织化学法观察L5脊髓节段小胶质细胞的表达情况,并在鞘内注射后第1,3,5,7天取L4-L5脊髓膨大节段检测NF-κB mRNA和CX3CR1mRNA的表达。结果:与MA组相比,sham组、PDTC预处理组及PDTC后处理组的大鼠同侧后肢各时间点痛阈值明显升高,差异有统计学意义(P<0.05);与MA组相比,PDTC预处理组及PDTC后处理组大鼠的L5脊髓节段的小胶质细胞数量明显减少,脊髓中CX3CR1mRNA和NF-κB mRNA的表达均明显减少,差异均有统计学意义(均P<0.05)。结论:鞘内注射NF-κB抑制剂PDTC可以缓解CFA所致MA模型大鼠的痛觉异常。其机制可能与NF-κB信号通路通过调节CX3CR1的表达而参与炎性痛的发生、发展有关。
Objective To observe the effect of intrathecal injection of nuclear factor-κB ( NF-κB) inhibitor of pyrrolidine dithiocarbamate ( PDTC) on pain sensitivity thresholds and the expression of spinal cord CX3C chemokine receptor 1 ( CX3CR1 ) in monoarthritis ( MA ) model in rats. Methods Forty-eight Sprague-Dawley rats were randomly divided into 4 groups ( 12 each ) after successful intrathecal catheterization: ( 1 ) sham operation with physiological saline group ( the sham group) ; ( 2) MA with normal saline group ( the MA group) ; ( 3) 10 μL 100 μmol/L PDTC before MA ( the PDTC pre-treatment group) ; ( 4 ) MA before 10 μL 100 μmol/L PDTC ( the PDTC post-treatment group) . Normal saline or PDTC was injected 5 d after the intrathecal catheterization. Pain sensitivity thresholds were measured in the 4 groups before and after the intrathecal injection at different time points. Rat monoarthritis model was subsequently built by injecting complete Freund’s adjuvant ( CFA) into the left ankle joint of the rats. On day 3 after the intrathecal injection,expression of microglia in the L5 spinal cord segment was observed by immunohistochemical method,and the lumbar segments L4 - L5 of spinal cord were taken to perform RT-PCR to examine the expression of NF-κB mRNA and CX3 CR1 mRNA. Results Compared with the MA group,the pain sensitivity thresholds in the sham group,the PDTC pre-treatment group and the PDTC post-treatment group at each time point after the intrathecal injection increased significantly ( P 0. 05) ,while microglia in the L5 spinal cord segment decreased significantly ( P 0. 05 ) and expression of CX3CR1 mRNA and NF-κB mRNA in the lumbar segments L4 - L5 of spinal cord decreased significantly ( P 0. 05) . Conclusion The hyperalgesic effect of the CFA-induced model of monoarthritis can be relieved by intrathecal injection of NF-κB inhibitor PDTC. Its mechanism is possibly related to NF-κB signal pathway which is involved in the formation of inflammatory pain through regulating CX3CR1 expression.
出处
《中南大学学报(医学版)》
CAS
CSCD
北大核心
2010年第11期1167-1173,共7页
Journal of Central South University :Medical Science